MedPath

Fludrocortisone Acetate

Fludrocortisone Acetate Tablets, USP (0.1 mg)

Approved
Approval ID

4ed382df-f2d5-46a4-a68b-aba807777093

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 6, 2024

Manufacturers
FDA

Amneal Pharmaceuticals of New York LLC

DUNS: 123797875

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

FLUDROCORTISONE ACETATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0115-7033
Application NumberANDA040431
Product Classification
M
Marketing Category
C73584
G
Generic Name
FLUDROCORTISONE ACETATE
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 6, 2024
FDA Product Classification

INGREDIENTS (5)

FLUDROCORTISONE ACETATEActive
Quantity: 0.1 mg in 1 1
Code: V47IF0PVH4
Classification: ACTIB
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Fludrocortisone Acetate - FDA Drug Approval Details